ESMA has published a document addressing queries from competent authorities on the implementation of EMIR which may prove useful to investors and market participations in clarifying the requirements under the regulation. The document answers a significant number of questions relating to OTC derivatives, central counterparties, trade repositories and around reporting obligations.
- How-to guide How-to guide: The appointed representatives regime explained - what it means in practice (UK) Recently updated
- Checklist Checklist: Pre-appointment checks to consider when selecting an appointed representative (UK) Recently updated
- Checklist Checklist: Preparing an application to vary a Part 4A permission at the request of a firm (UK)